Letters, Testimony & Comments

BIO submits letters, testimony, and comments to government and regulatory bodies throughout the United States and around the world.

Featured Letters, Testimony, & Comments
BIO Letter to HRSA on 340B Rebate Model
Under the 340B program, participating manufacturers must offer 340B pricing on their covered outpatient drugs by covered entities, as a condition of having those drugs federally payable under Medicare Part B and Medicaid. Critically, Congress…
CSBA Letter to Congressional Leadership on…
BIO Comments to the USPTO’s MAY 10, 2024 Proposed…
BIO submitted these comments in response to the United States Patent and Trademark Office’s May 10, 2024, Notice of Proposed Rulemaking regarding Terminal Disclaimer Practice to Obviate Nonstatutory Double Patenting.
All Letters, Testimony & Comments
  • Show All
Search
Results
May 17, 2021
The undersigned food, agriculture, and seafood trade associations respectfully urge the expeditious nomination of the Chief Agricultural Negotiator at the Office of the U.S. Trade Representative. America’s farmers, ranchers, processors, exporters…
May 13, 2021
The undersigned trade associations and private sector organizations write to express our strong support for the Endless Frontier Act, sponsored by Senate Majority Chuck Schumer (D-NY) and Senator Todd Young (R-IN), which would provide much needed,…
May 12, 2021
Dr. Michelle McMurry-Heath, along with a group of business and policy leaders, sends an open letter to President Biden urging him "to demonstrate decisive U.S. leadership" to combat COVID-19 in Latin America, Europe, Asia, and Africa…
April 29, 2021
The farmers, ranchers, agricultural retailers, cooperatives, researchers, scientists, seed producers, and technology developers represented by the organizations signed below appreciate the opportunity to provide input for the United States…
April 29, 2021
The Biotechnology Innovation Organization (BIO) is pleased to respond to the U.S. Department of Agriculture’s (USDA) Request for Comments: Executive Order on Tackling the Climate Crisis at Home and Abroad as USDA develops a Climate-Smart…
April 27, 2021
On behalf of the Biotechnology Innovation Organization (BIO), the global industry organization representing the biotechnology industry, I want to express support for House Bill 1091, which recently passed the Washington Legislature. BIO member…
April 23, 2021
We write to you in strong support of President Biden’s nomination of Jewel Bronaugh, PhD to serve as Deputy Secretary of Agriculture and ask that you quickly approve her nomination. As leaders of the nation’s food and agricultural organizations, we…
April 9, 2021
The Biotechnology Innovation Organization (BIO) submitted the below comments to the National Institute of Standards and Technology on proposed revisions to regulations that would further the Return on Investment (ROI) Initiative for Unleashing…
April 6, 2021
On Tuesday, April 6th, BIO submitted comments on the U.S. Food and Drug Administration (FDA)’s January 2021 draft industry guidance on “Human Gene Therapy for Neurodegenerative Diseases.” In its comments, BIO stated that while the guidance covers…